LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

2021 AACC Annual Scientific Meeting & Clinical Lab Expo to Offer Free Onsite COVID-19 Testing

By LabMedica International staff writers
Posted on 09 Sep 2021
Print article
Illustration
Illustration
In its ongoing efforts to make the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo safe and healthy, the American Association for Clinical Chemistry (AACC; Washington, DC, USA), in association with LumiraDx (London, UK), will offer free onsite COVID-19 testing to all in-person attendees.

This year's AACC Annual Scientific Meeting, held in partnership with the Canadian Society of Clinical Chemists, will be a live event and has moved from Anaheim to Atlanta due to stringent COVID-19 lockdown requirements in California, with the meeting dates also being moved by one week to September 26-30. The latest move to offer onsite COVID-19 testing at the in-person meeting comes on top of the event’s already robust safety protocols that require all meeting participants to be vaccinated, and all meeting participants to have received a negative PCR or antigen COVID-19 test within 72 hours of arriving at the convention center.

To make the testing requirement as convenient as possible, AACC in association with LumiraDX will provide an onsite mobile testing unit outside the convention centre main doors where all in-person attendees can obtain a free COVID-19 test on a first come, first served basis. The results will take 30 minutes from sample collection. Attendees can avoid the necessity of fitting testing into their conference schedule by securing a test before leaving for Atlanta, as long as it falls within the three-day window. Additionally, the AACC will provide the attendees with COVID-19 self-test packets while they are at the conference and also as they prepare to return home, although supplies will be limited to the first 3,000 requests.

Related Links:
American Association for Clinical Chemistry
LumiraDx


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
ADLM

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more